Cleared Special

K140141 - LABONACHECK GLUPPY BLOOD GLUCOSE MONITORING SYSTEM

K140141 is an FDA 510(k) clearance for LABONACHECK GLUPPY BLOOD GLUCOSE MONITO..., manufactured by Ceragem Medisys, Inc.. The device is a Class 2 Chemistry device with product code NBW cleared through the Special 510(k) pathway after a 162-day FDA review.

K140141 · Ceragem Medisys, Inc. · Chemistry device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jul 2014
Decision
162d
Days
Class 2
Risk

K140141 is an FDA 510(k) clearance for the LABONACHECK GLUPPY BLOOD GLUCOSE MONITORING SYSTEM. Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Ceragem Medisys, Inc. (Cheonan, Chungcheongnam-Do, KR). The FDA issued a Cleared decision on July 3, 2014 after a review of 162 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

FDA 510(k) Submission Details - K140141

510(k) Number K140141 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 22, 2014
Decision Date July 03, 2014
Days to Decision 162 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
73d slower than avg
Panel avg: 89d · This submission: 162d
Pathway characteristics
Modification to existing cleared device.

NBW Device Classification - Class 2, Special Controls

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 513
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K140141.
OKMETER DIRECT BLOOD GLUCOSE MONITORING SYSTEM
K132633 · Ok Biotech Co., Ltd. · Aug 2014
GMATE SMART BLOOD GLUCOSE MONITORING SYSTEM, GMATE SMART APPLICATION
K131230 · Philosys, Inc. · Aug 2014
TRUE METRIX SELF-MONITORING BLOOD GLUCOSE SYSTEM, TRUE METRIX PRO PROFESSIONAL MONITORING BLOOD GLUCOSE SYSTEM
K140100 · Nipro Diagnostics, Inc. · Aug 2014
MEDISIGN BLOOD GLUCSE MONITORING SYSTEM, MEDISIGN MULTI BLOOD GLUCOSE MONITORING SYSTEM
K133260 · Tianjin Empecs Medical Device Co., Ltd. · Jun 2014
IDEAL LIFE GLUCO-MANAGER BLOOD GLUCOSE MONITORING SYSTEM
K132180 · Ideal Life, Inc. · Jun 2014
CONTOUR NEXT EZ BLOOD GLUCOSE METER
K130265 · Bayer Healthcare, LLC · Jun 2014
K140141 · LABONACHECK GLUPPY BLOOD GLUCOSE MONITORING SYSTEM
Download PDF FDA Summary Ceragem Medisys, Inc.